Rainbow Childrens Medicare Limited will hold its 28th Annual General Meeting (AGM) on Wednesday, July 29, 2026, at 10:00 AM IST through video conferencing. The meeting will be conducted in compliance with the Companies Act, 2013, and relevant SEBI regulations, permitting the event without physical presence at a common venue. The corporate office in Banjara Hills, Hyderabad, will serve as the deemed venue for the proceedings.

The Board of Directors, at its meeting held on May 23, 2026, recommended a final dividend of ₹3.35 per equity share for the financial year ended March 31, 2026. This dividend distribution is subject to the approval of the members at the upcoming AGM. Shareholders whose names appear in the Register of Members or the list of beneficial owners maintained by depositories as of Tuesday, July 21, 2026, will be eligible to receive the payout.

Dividend and Taxation Details

The company has specified that dividends will be paid exclusively through electronic mode. Shareholders are advised to ensure their bank account details, including account number, bank name, branch details, and IFSC code, are updated with their respective depository participants to facilitate timely credit. Additionally, pursuant to the provisions of the Income-tax Act, 2025, the dividend will be paid after deduction of tax at source at applicable rates. Members must ensure their Permanent Account Number (PAN) and residential status are updated to determine the correct tax deduction rate.

Meeting Logistics and Documentation

In compliance with Ministry of Corporate Affairs and SEBI circulars, the notice for the 28th AGM and the Annual Report for FY 2025-26 will be dispatched electronically. Shareholders with registered email addresses will receive these documents directly. A letter containing a QR code and web-link for accessing the reports will be sent to those whose email addresses are not registered. The company noted that as of the notice date, there are no shareholders holding shares in physical form.

The documents will also be available on the company’s website and the websites of BSE Limited and National Stock Exchange of India Limited. Members will have the opportunity to cast their votes electronically through remote e-voting and during the AGM via the e-voting facility. Detailed procedures for participation and voting are outlined in the AGM notice.

[Rainbow Children's Medicare Limited](rainbow childrens medicare) has reported a 15.3% increase in consolidated net profit to ₹2,815.44 million for the financial year ended March 31, 2026, compared to ₹2,442.27 million in the previous year. Revenue from operations for the year rose 12.4% to ₹17,030.77 million from ₹15,158.66 million in FY25. The board of directors, in its meeting held on May 23, 2026, approved the audited standalone and consolidated financial results and recommended a final dividend of ₹3.5 per equity share. The company’s strong performance was driven by healthy momentum across operating metrics, including outpatient footfalls, inpatient discharges, and deliveries, alongside the successful commissioning of new facilities in Bengaluru.

Financial Performance

The company’s profitability improved alongside revenue growth. For the full year, total income reached ₹17,468.65 million, while total expenses stood at ₹13,870.97 million. Profit before tax for the year was ₹3,582.29 million. On a standalone basis, net profit for FY26 was ₹2,500.16 million, with revenue from operations reaching ₹15,456.60 million. EBITDA for the year rose 11.1% to ₹5,442 million, with an EBITDA margin of 32.0%.

The following table summarizes the key consolidated financial figures for the full year:

Q4 Performance

In the quarter ended March 31, 2026, consolidated net profit stood at ₹782.18 million, a 38.3% increase from ₹565.53 million in the same quarter of the previous year. Revenue from operations reached ₹4,599.01 million, compared to ₹3,701.07 million year-on-year. EBITDA for the quarter rose 26.1% to ₹1,447 million, with the EBITDA margin expanding to 31.5% from 31.0%. On a standalone basis, net profit for the quarter was ₹593.05 million on revenue of ₹4,080.64 million.

Operational Highlights

The company maintained robust operational metrics during the year. Capacity beds increased 23% to 2,375, while operational beds grew 10% to 1,677. Occupancy for the year stood at 46.26%. Inpatient discharges rose 6% to 104,514, and outpatient consultations increased 12% to 15,98,970. Deliveries for the year reached 19,228. The Average Revenue Per Occupied Bed (ARPOB) improved 11% to ₹60,141, while the Average Length of Stay (ALOS) decreased to 2.71 days from 2.85 days in the previous year.

Dividend and Appointments

The board has recommended a final dividend of ₹3.5 per equity share, representing 35% on a face value of ₹10 per share for FY26. The total dividend payout aggregates to ₹355.46 million. The record date for determining eligibility has been fixed as July 21, 2026, and the payment is subject to shareholder approval at the 28th Annual General Meeting scheduled for July 29, 2026.

The board approved the re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director and Dr. Dinesh Kumar Chirla as Whole Time Director for a period of five years from August 11, 2026. Additionally, Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati were re-appointed as Independent Directors for second terms of five years each. M/s. Lavanya & Associates LLP were re-appointed as Cost Auditors for FY27.

Investor Conference Call

Pursuant to Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the audio recording of the conference call held on May 25, 2026, with investors and analysts to discuss the financial and operational performance for Q4 and FY26 is now available on the company's website.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE961O01016/765b96f7-e995-470a-8cee-a3fbf38a46af.pdf